Show simple item record

dc.contributor.authorGallagher, Cathal
dc.contributor.authorAtik, Sanaa
dc.contributor.authorIsse, Libin
dc.contributor.authorMann, Sanpreet
dc.date.accessioned2020-03-02T02:04:44Z
dc.date.available2020-03-02T02:04:44Z
dc.date.issued2020-02-03
dc.identifier.citationGallagher , C , Atik , S , Isse , L & Mann , S 2020 , ' Doctor or drug dealer? International legal provisions for the legitimate handling of drugs of abuse ' , Drug Science, Policy and Law , vol. 6 . https://doi.org/10.1177/2050324519900070
dc.identifier.issn2050-3245
dc.identifier.otherORCID: /0000-0002-2107-4522/work/141599669
dc.identifier.urihttp://hdl.handle.net/2299/22360
dc.description© The Author(s) 2020. The final, definitive version of this paper has been published in: Gallagher, C. T., Atik, S. K., Isse, L., & Mann, S. K. (2020). Doctor or drug dealer? International legal provisions for the legitimate handling of drugs of abuse. Drug Science, Policy and Law. by Sage Publications Ltd. All rights reserved. It is available at: https://doi.org/10.1177/2050324519900070
dc.description.abstractIn this paper, we compare how five jurisdictions (the USA; UK; Canada; New Zealand; and Australia) balance the disparate objectives of preventing the misuse of drugs to the detriment of society and allowing their legal for societally-beneficial purposes. The statutory law underpinning each country’s method of categorising drugs depict distinctive outlooks from the different jurisdictions, as each works towards these same goals. In examining how each country’s legislation deals with controlled substances, initial consideration will be given to whether drugs are categorised once only, or twice: once for dealing with their criminal misuse; and again for ensuring their safe medicinal use. In effectively dealing with criminal activities associated with drugs of abuse, Australia’s system of imposing penalties based on the quantity of a drug possessed, rather than on its grouping with other drugs of a broadly similar type offers the most flexibility. In terms of managing the legitimate use of such drugs, however, it is perhaps the least flexible of the four jurisdictions operating parallel systems of categorisation. The greatest level of flexibility is offered by Canada and the UK, which have functionally very similar protocols in this respect.en
dc.format.extent570484
dc.language.isoeng
dc.relation.ispartofDrug Science, Policy and Law
dc.titleDoctor or drug dealer? International legal provisions for the legitimate handling of drugs of abuseen
dc.contributor.institutionDepartment of Clinical and Pharmaceutical Sciences
dc.contributor.institutionCentre for Health Services and Clinical Research
dc.contributor.institutionPublic Health and Patient Safety Unit
dc.contributor.institutionSchool of Life and Medical Sciences
dc.contributor.institutionDepartment of Clinical, Pharmaceutical and Biological Science
dc.description.statusPeer reviewed
rioxxterms.versionofrecord10.1177/2050324519900070
rioxxterms.typeJournal Article/Review
herts.preservation.rarelyaccessedtrue


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record